Published in J Clin Med Res on July 26, 2011
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95
Natriuretic peptides. J Am Coll Cardiol (2007) 3.91
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol (2005) 3.85
NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J (2005) 2.93
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation (2002) 2.85
Effect of aging and physical activity on left ventricular compliance. Circulation (2004) 2.68
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol (2005) 2.34
Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol (2004) 2.27
B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis (2005) 2.24
B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial. Ann Intern Med (2009) 2.18
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol (2006) 1.98
Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol (2009) 1.87
Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol (2003) 1.80
B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis (2003) 1.74
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail (2004) 1.66
Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older. J Am Geriatr Soc (2005) 1.54
Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol (2005) 1.45
Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol (2006) 1.31
N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail (2004) 0.94
Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol (2005) 0.93
Blood haemoglobin is an independent predictor of B-type natriuretic peptide (BNP). Clin Sci (Lond) (2005) 0.90
A clinical and biochemical critical pathway for the evaluation of patients with suspected acute congestive heart failure: The ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) algorithm. Crit Pathw Cardiol (2004) 0.85
Effect of anemia on plasma concentrations of NT-proBNP. Clin Chim Acta (2005) 0.84
Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis. Eur J Heart Fail (2005) 0.83
Cardiovascular disease in patients with chronic renal impairment: role of natriuretic peptides. Congest Heart Fail (2008) 0.82
Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department. Am Heart J (2006) 0.78
Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study. Clin Chim Acta (2007) 0.77
Effect of renal function loss on NT-proBNP level variations. Clin Biochem (2009) 0.76
Classifying free-text triage chief complaints into syndromic categories with natural language processing. Artif Intell Med (2005) 3.37
Detection of pediatric respiratory and diarrheal outbreaks from sales of over-the-counter electrolyte products. J Am Med Inform Assoc (2003) 2.97
The effect of a six-week program of yoga and meditation on brachial artery reactivity: do psychosocial interventions affect vascular tone? Clin Cardiol (2006) 1.69
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. J Am Coll Cardiol (2009) 1.42
Data, network, and application: technical description of the Utah RODS Winter Olympic Biosurveillance System. Proc AMIA Symp (2002) 1.26
Acute kidney injury predicts outcomes of non-critically ill patients. Mayo Clin Proc (2009) 1.03
Effectiveness of a multidisciplinary quality improvement initiative in reducing door-to-balloon times in primary angioplasty. J Interv Cardiol (2004) 0.89
In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi. Vet Microbiol (2010) 0.86
Aspirin resistance: an update. Curr Atheroscler Rep (2009) 0.85
Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol (2007) 0.85
Influence of diabetes and/or myocardial infarction on prevalence of abnormal T-wave alternans. Ann Noninvasive Electrocardiol (2009) 0.82
Plaque disruption and thrombus in Ambrose's angiographic coronary lesion types. Am J Cardiol (2003) 0.81
Benzocaine-induced methemoglobinemia: a potentially fatal complication of transesophageal echocardiography. Tex Heart Inst J (2003) 0.80
Simultaneous temperature and strain measurements performed by a step-changed arc-induced long-period fiber grating. Appl Opt (2007) 0.77
Serial evaluation of microcirculatory dysfunction in patients with Takotsubo cardiomyopathy by myocardial contrast echocardiography. Clin Cardiol (2013) 0.76
Letter by Lancaster et al regarding article, "Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure". Circulation (2009) 0.75
Editorial: What have we lost in the wake of the rosiglitazone controversy? Endocr Pract (2009) 0.75
Coronary thrombosis related to use of Xenadrine RFA. Tex Heart Inst J (2005) 0.75
Previous aspirin use in acute coronary syndromes: more than a marker? J Am Coll Cardiol (2011) 0.75
Life-threatening hyperkalemia: a potentially lethal drug combination. Conn Med (2013) 0.75
The role of aspirin resistance in the treatment of acute coronary syndromes. Clin Cardiol (2008) 0.75
Images in cardiovascular medicine. Dramatic left atrial and ventricular hypertrophy in an adult with cyanotic congenital heart disease. Circulation (2003) 0.75
Ataxia and cranial neuropathies from subcutaneously injected elemental mercury. Clin Toxicol (Phila) (2011) 0.75